日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Development and validation of the FAAP model for prognostic stratification in HCC patients treated with TACE, sintilimab plus bevacizumab: a multicenter study

FAAP模型在接受TACE、信迪利单抗联合贝伐珠单抗治疗的肝细胞癌患者预后分层中的开发和验证：一项多中心研究

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1692632
Ren, Liying; Chen, Dongbo; Zhang, Xue; She, Shaoping; Fei, Ran; Cong, Xu; Mu, Shaowei; Zhou, Yuchen; Gao, Jie; Liao, Weijia; Chen, Hongsong
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Hemopexin Suppresses Hepatocellular Carcinoma via TNF-α-Mediated Mitochondrial Apoptosis.

血红素结合蛋白通过TNF-α介导的线粒体凋亡抑制肝细胞癌。

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17182969
Ren Liying, Man Yuxin, Zhang Xue, Guo Qian, She Shaoping, Yang Yao, Fei Ran, Cong Xu, Chen Dongbo, Wei Wen, Chen Hongsong
肿瘤
凋亡
表观遗传
肿瘤免疫
Apoptosis
TNF-α
线粒体
细胞生物学
发表日期：2025
文献求助 收藏

CT Radiomics Combined with Metabolic-Biomarkers Enables Early Recurrence Prediction in Hepatocellular Carcinoma

CT放射组学结合代谢生物标志物可实现肝细胞癌的早期复发预测

期刊:Journal of Hepatocellular Carcinoma
影响因子:3.4
doi:10.2147/JHC.S547186
Ren, Liying; Chen, Dongbo; Xu, Tingfeng; Wei, Rongyu; Zhao, Bigeng; Zhou, Yuanping; He, Yong; Liao, Minjun; Chen, Hongsong; Liao, Weijia
细胞生物学
肿瘤
肿瘤免疫
代谢
发表日期：2025
文献求助 收藏

Development of a nomogram for predicting microvascular invasion in patients with hepatocellular carcinoma

构建用于预测肝细胞癌患者微血管侵犯的列线图

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-15257-8
Li, Jun; Huo, Shengjun; Ma, Jun; Ren, Liying; Liu, Lingling; Lu, Yu; Tang, Songyun; Chen, Dongbo; Jin, Lei; Liao, Weijia
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Research on road surface damage detection based on SEA-YOLO v8

基于SEA-YOLO v8的路面损伤检测研究

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0324439
Zhao, Yuxi; Shi, Baoyong; Duan, Xiaoguang; Zhu, Wenxing; Ren, Liying; Liao, Chang
发表日期：2025
文献求助 收藏

The ratio of GGT to PLT indices is a predictive factor for the progression of liver fibrosis in NA-treated chronic hepatitis B patients with advanced fibrosis plus PEG-IFN α-2a therapy: a case-control study

GGT/PLT比值是接受核苷（酸）类似物（NA）治疗的伴有晚期肝纤维化的慢性乙型肝炎患者加PEG-IFN α-2a治疗后肝纤维化进展的预测因子：一项病例对照研究

期刊:BMC Gastroenterology
影响因子:2.6
doi:10.1186/s12876-025-04508-4
Li, Ling; Li, Huili; Zhao, Yiru; Shi, Lisha; Suwanbai, Mireyi; Ren, Liying; Li, Guojun; Pan, Xiucheng
肝炎
发表日期：2025
文献求助 收藏

Bridging the Gap Between Imaging and Molecular Characterization: Current Understanding of Radiomics and Radiogenomics in Hepatocellular Carcinoma

弥合影像学与分子表征之间的差距：目前对肝细胞癌放射组学和放射基因组学的理解

期刊:Journal of Hepatocellular Carcinoma
影响因子:3.4
doi:10.2147/JHC.S423549
Ren, Liying; Chen, Dong Bo; Yan, Xuanzhi; She, Shaoping; Yang, Yao; Zhang, Xue; Liao, Weijia; Chen, Hongsong
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Dominant neoantigen verification in hepatocellular carcinoma by a single-plasmid system coexpressing patient HLA and antigen

利用共表达患者HLA和抗原的单质粒系统验证肝细胞癌中的优势新抗原

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2022-006334
Chen, Pu; Chen, Dongbo; Bu, Dechao; Gao, Jie; Qin, Wanying; Deng, Kangjian; Ren, Liying; She, Shaoping; Xu, Wentao; Yang, Yao; Xie, Xingwang; Liao, Weijia; Chen, Hongsong
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Development and validation of a nomogram for evaluating the incident risk of carotid atherosclerosis in patients with type 2 diabetes

开发和验证用于评估2型糖尿病患者颈动脉粥样硬化发生风险的列线图

期刊:Frontiers in Endocrinology
影响因子:4.6
doi:10.3389/fendo.2023.1131430
Feng, Xiao; Ren, Liying; Xiang, Yuping; Xu, Yancheng
糖尿病
心血管
动脉粥样硬化
代谢
发表日期：2023
文献求助 收藏

Prognosis and therapeutic benefits prediction based on NK cell marker genes through single-cell RNA-seq with integrated bulk RNA-seq analysis for hepatocellular carcinoma

基于NK细胞标志基因的单细胞RNA测序结合整合的批量RNA测序分析预测肝细胞癌的预后和治疗获益

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2023.1208165
Yang, Yao; She, Shaopin; Ren, Liying; Zhao, Bigeng; Chen, Dongbo; Chen, Hongsong
细胞生物学
肿瘤
肿瘤免疫
单细胞
发表日期：2023
文献求助 收藏